Uniquity Bio
Brian Lortie is a seasoned executive in the biopharmaceutical industry, currently serving as Founder, Board Director, and Advisor at Uniquity Bio since January 2022, following a tenure as its CEO. With extensive experience leading clinical-stage companies, Brian's previous roles include President and CEO of Onspira Therapeutics, where the focus was on developing therapies for rare pulmonary diseases, and President of Branded Pharmaceuticals at Endo Pharmaceuticals, overseeing comprehensive business operations. Brian's earlier career at GlaxoSmithKline involved various leadership positions, culminating in roles such as VP and Global Head of HPV Vaccine Development. Academically, Brian holds a BA cum laude in Psychology and Biology from Boston University and has pursued graduate study in Business Administration at Villanova School of Business.
This person is not in any offices